Periocular and orbital amyloidosis: A case series study

Author:

Kadir Syeed Mehbub Ul1ORCID,Haider Golam2,Mitra Mukti Rani,Maurya Rajendra Prakash,Parveen Nishat,Hossain Tanjila,Rashid Riffat,Hossain Md. Ismail,Bhowmik Narayon Chandra,Sultana Sadia

Affiliation:

1. Sheikh Fazilatunnesa Mujib Eye Hospital & Training Institute, Gopalganj, Bangladesh, India

2. h

Abstract

To present the demographic and clinical profile and management strategies of patients with periocular and orbital amyloidosis. This study retrospectively reviewed the clinical records of twelve patients with periocular and orbital amyloidosis between January 2011 and February 2019 in Bangladesh. Clinical evaluation and Imaging studies were helpful to diagnosis the patients, but surgical biopsy followed by histopathological study was done to confirm the diagnosis. All cases were investigated to rule out systemic amyloidosis with limited facility and no systemic involvement was found. Informed written consent for surgical procedure and Clinical photographs were taken for all patients for documentation and clinical research. The study included thirteen patients including nine male (69.2%) and four female (30.8%) patients. Among the patients, seven (53.8%) were unilateral and six (46.2%) were bilateral. Clinical signs and symptoms were visible or palpable periocular mass or tissue infiltration in all 13 (100%) cases, mechanical ptosis was observed in 6 (46.2%) cases, and proptosis or globe displacement was found in 4 (30.8%). Age ranges from 25 years to 65 years. The Mean age ± SD was 48.23 ± 10.64 years. Treatment modalities were mainly open surgical biopsy either excision (53.8%) or debulking (46.2%). Periocular and orbital amyloidosis may present with a wide spectrum of clinical findings depending on the location of the disease. The goal of treatment is to preserve function and to prevent sight-threatening complications.

Publisher

IP Innovative Publication Pvt Ltd

Subject

Marketing,Organizational Behavior and Human Resource Management,Strategy and Management,Drug Discovery,Pharmaceutical Science,Pharmacology

Reference27 articles.

1. Hrisomalos F, Pattar GR, Phelps PO, MT Yen , MM Marcet , CN Burkat, Ocular Amyloidosis. Eye Wiki..

2. Amyloid Fibril Protein Nomenclature - 2002

3. Ocular adnexal and orbital amyloidosis: a case series and literature review

4. Rootman J, .Degenerations and depositions. Diseases of the Orbit: A Multidisciplinary Approach.555-64

5. Nomenclature of amyloid and amyloidosis. WHO-IUIS Nomenclature Sub-Committee.Bull World Health Organ 1993;71(1):105-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3